SI2137143T1 - Plevromutilinski derivati za zdravljenje bolezni, posredovanih z mikrobi - Google Patents

Plevromutilinski derivati za zdravljenje bolezni, posredovanih z mikrobi

Info

Publication number
SI2137143T1
SI2137143T1 SI200830451T SI200830451T SI2137143T1 SI 2137143 T1 SI2137143 T1 SI 2137143T1 SI 200830451 T SI200830451 T SI 200830451T SI 200830451 T SI200830451 T SI 200830451T SI 2137143 T1 SI2137143 T1 SI 2137143T1
Authority
SI
Slovenia
Prior art keywords
alkyl
microbes
treatment
cycloalkyl
diseases mediated
Prior art date
Application number
SI200830451T
Other languages
English (en)
Slovenian (sl)
Inventor
Rosemarie Mang
Werner Heilmayer
Rudolf Badegruber
Dirk Strickmann
Rodger Novak
Mathias Ferencic
Atchyuta Rama Chandra Murty Bulusu
Original Assignee
Nabriva Therapeutics Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38668870&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2137143(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nabriva Therapeutics Ag filed Critical Nabriva Therapeutics Ag
Publication of SI2137143T1 publication Critical patent/SI2137143T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/61Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/93Spiro compounds
    • C07C2603/95Spiro compounds containing "not free" spiro atoms
    • C07C2603/98Spiro compounds containing "not free" spiro atoms containing at least one ring with more than six ring members
    • C07C2603/99Spiro compounds containing "not free" spiro atoms containing at least one ring with more than six ring members containing eight-membered rings
SI200830451T 2007-03-20 2008-03-19 Plevromutilinski derivati za zdravljenje bolezni, posredovanih z mikrobi SI2137143T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07450053A EP1972618A1 (de) 2007-03-20 2007-03-20 Pleuromutilin-Derivate zur Behandlung von Krankheiten vermittelt durch Mikroben
PCT/AT2008/000097 WO2008113089A1 (en) 2007-03-20 2008-03-19 Pleuromutilin derivatives for the treatment of diseases mediated by microbes
EP08714294A EP2137143B1 (de) 2007-03-20 2008-03-19 Pleuromutilinderivate zur behandlung von durch mikroben vermittelten krankheiten

Publications (1)

Publication Number Publication Date
SI2137143T1 true SI2137143T1 (sl) 2012-01-31

Family

ID=38668870

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200830451T SI2137143T1 (sl) 2007-03-20 2008-03-19 Plevromutilinski derivati za zdravljenje bolezni, posredovanih z mikrobi

Country Status (32)

Country Link
US (12) US20090118366A1 (de)
EP (3) EP1972618A1 (de)
JP (2) JP5479114B2 (de)
KR (1) KR101478593B1 (de)
CN (2) CN101668738B (de)
AT (1) ATE523486T1 (de)
AU (1) AU2008229609B2 (de)
BR (1) BRPI0809023B8 (de)
CA (1) CA2678795C (de)
CY (2) CY1117482T1 (de)
DK (2) DK2137143T3 (de)
EA (1) EA018707B1 (de)
ES (2) ES2620459T3 (de)
FI (1) FIC20200038I1 (de)
HK (1) HK1140185A1 (de)
HR (1) HRP20110869T1 (de)
HU (1) HUS2100001I1 (de)
IL (1) IL200440A (de)
LT (1) LTPA2020531I1 (de)
MA (1) MA31314B1 (de)
MY (1) MY148916A (de)
NL (1) NL301086I2 (de)
NO (1) NO2021002I1 (de)
NZ (1) NZ579011A (de)
PL (1) PL2137143T3 (de)
PT (2) PT2380874T (de)
SI (1) SI2137143T1 (de)
TN (1) TN2009000347A1 (de)
TW (1) TWI406657B (de)
UA (1) UA97836C2 (de)
WO (1) WO2008113089A1 (de)
ZA (1) ZA200905590B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1808431A1 (de) * 2006-01-16 2007-07-18 Nabriva Therapeutics Forschungs GmbH Mutilin Derivate und ihre Verwendung als Arzneimittel
EP1972618A1 (de) 2007-03-20 2008-09-24 Nabriva Therapeutics AG Pleuromutilin-Derivate zur Behandlung von Krankheiten vermittelt durch Mikroben
EP2159220A1 (de) * 2008-09-02 2010-03-03 Nabriva Therapeutics AG Organische Verbindungen
WO2010056855A1 (en) * 2008-11-13 2010-05-20 Teva Pharmaceutical Industries Ltd. Preparation of retapamulin via its pleuromutilin-thiol precursor
EP2390245A1 (de) 2010-05-26 2011-11-30 Nabriva Therapeutics AG Enantiomerisch reine Amine
EP2399904A1 (de) * 2010-05-26 2011-12-28 Nabriva Therapeutics AG Verfahren zur Herstellung von Pleuromutilinen
EP2433926A1 (de) 2010-09-09 2012-03-28 Nabriva Therapeutics AG Pleuromutilin-Derivate zur Behandlung von Krankheiten vermittelt durch Mikroben
WO2013010882A2 (de) 2011-07-15 2013-01-24 Bayer Intellectual Property Gmbh 2,3-diphenyl-valeronitrilderivate, verfahren zu deren herstellung und deren verwendung als herbizide und pflanzenwachstumsregulatoren
CN103265487A (zh) * 2013-06-05 2013-08-28 北京理工大学 截短侧耳素扩环衍生物及其制备方法和用途
CN104803911B (zh) * 2014-01-23 2018-01-05 中国科学院上海药物研究所 一类截短侧耳素化合物、其药物组合物、合成方法与用途
ES2553929B1 (es) * 2014-06-11 2016-09-26 Antonio Javier MORENO CASTRO Dispositivo de modificación/destrucción selectiva de tejidos orgánicos
LT3310331T (lt) * 2015-06-17 2021-01-11 Nabriva Therapeutics GmbH Švirkščiamos lefamulino farmacinės kompozicijos
PL3310333T3 (pl) 2015-06-18 2020-07-13 Estetra Sprl Ulegająca rozpadowi w jamie ustnej jednostka dawkowana zawierająca składnik estetrolowy
PL3106148T3 (pl) 2015-06-18 2018-08-31 Mithra Pharmaceuticals S A Jednostka dawkowania ulegająca rozpadowi w jamie ustnej zawierająca składnik estetrolowy
TWI762573B (zh) 2017-02-10 2022-05-01 奧地利商納畢瓦治療有限責任公司 截短側耳素之純化
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
CN111170911A (zh) * 2019-09-29 2020-05-19 安帝康(无锡)生物科技有限公司 用于治疗细菌感染性疾病的截短侧耳素类化合物
CN111170893B (zh) * 2020-01-19 2022-04-26 郑州依米花手性药物研究有限公司 Lefamulin的中间体化合物及其在Lefamulin制备中的应用
EP4135681A1 (de) * 2020-04-17 2023-02-22 Nabriva Therapeutics GMBH Neue therapeutische verwendung von pleuromutilinen
EP4135683A1 (de) 2020-04-17 2023-02-22 Nabriva Therapeutics GMBH Therapeutische verwendung von pleuromutilinen
TW202203908A (zh) 2020-04-17 2022-02-01 奧地利商納畢瓦治療有限責任公司 截短側耳素類之醫療用途
WO2023152115A1 (en) 2022-02-09 2023-08-17 Nabriva Therapeutics GmbH Lefamulin and its derivatives for use in the treatment of a spiral shaped bacteria
EP4338732A1 (de) 2022-09-16 2024-03-20 Nabriva Therapeutics GMBH Lefamulin und dessen derivate zur verwendung bei der behandlung von tularämie

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130709A (en) * 1977-12-08 1978-12-19 Eli Lilly And Company Pleuromutilin glycoside derivatives
DE4023848C2 (de) 1990-07-27 1994-04-21 Huels Chemische Werke Ag Verfahren zur Herstellung von 3-C¶1¶- bis C¶6¶-Alkoxycarbonylcyclohexanpropionsäureestern
GB9918037D0 (en) * 1999-07-30 1999-09-29 Biochemie Gmbh Organic compounds
GB0017031D0 (en) * 2000-07-11 2000-08-30 Biochemie Gmbh Antimicrobials
GB0207495D0 (en) 2002-03-28 2002-05-08 Biochemie Gmbh Organic compounds
GB0209262D0 (en) 2002-04-23 2002-06-05 Biochemie Gmbh Organic compounds
ES2295657T3 (es) * 2002-07-24 2008-04-16 Nabriva Therapeutics Forschungs Gmbh Derivados de pleuromutilina como antimicrobianos.
EP2298733B1 (de) * 2005-06-27 2016-05-25 Nabriva Therapeutics AG Pleuromutilinderivate mit einer Hydroxyamino- oder Acyloxyaminocycloalkylgruppe
GB0513058D0 (en) * 2005-06-27 2005-08-03 Sandoz Ag Organic compounds
GB0515995D0 (en) * 2005-08-03 2005-09-07 Sandoz Ag Organic compounds
EP1972618A1 (de) 2007-03-20 2008-09-24 Nabriva Therapeutics AG Pleuromutilin-Derivate zur Behandlung von Krankheiten vermittelt durch Mikroben

Also Published As

Publication number Publication date
US20100035987A1 (en) 2010-02-11
DK2380874T3 (en) 2017-03-27
MA31314B1 (fr) 2010-04-01
FIC20200038I1 (fi) 2020-10-01
TW200904402A (en) 2009-02-01
JP5479114B2 (ja) 2014-04-23
TN2009000347A1 (fr) 2010-12-31
US20170266194A1 (en) 2017-09-21
PL2137143T3 (pl) 2012-02-29
BRPI0809023B1 (pt) 2020-12-01
EA200970868A1 (ru) 2010-02-26
PT2380874T (pt) 2017-04-03
US20120029072A1 (en) 2012-02-02
IL200440A0 (en) 2010-04-29
JP5893651B2 (ja) 2016-03-23
US20180303842A1 (en) 2018-10-25
AU2008229609B2 (en) 2012-03-29
UA97836C2 (ru) 2012-03-26
CA2678795A1 (en) 2008-09-25
US20190175603A1 (en) 2019-06-13
NL301086I2 (nl) 2021-01-28
EP2137143A1 (de) 2009-12-30
EP1972618A1 (de) 2008-09-24
DK2137143T3 (da) 2012-01-02
CY1117482T1 (el) 2017-04-26
US20130040954A1 (en) 2013-02-14
CY2020032I1 (el) 2020-11-25
CN101668738B (zh) 2014-10-15
US8153689B2 (en) 2012-04-10
ES2620459T3 (es) 2017-06-28
LTPA2020531I1 (lt) 2020-11-10
US20090118366A1 (en) 2009-05-07
EP2137143B1 (de) 2011-09-07
HUS2100001I1 (hu) 2021-03-01
EP2380874A3 (de) 2011-12-07
NO2021002I1 (no) 2021-01-15
NZ579011A (en) 2011-03-31
US8071643B2 (en) 2011-12-06
ZA200905590B (en) 2010-10-27
EP2380874B1 (de) 2016-12-28
BRPI0809023A2 (pt) 2014-09-23
BRPI0809023B8 (pt) 2021-05-25
EP2380874A2 (de) 2011-10-26
JP2014159416A (ja) 2014-09-04
CA2678795C (en) 2014-11-18
KR20090123882A (ko) 2009-12-02
CN104211624A (zh) 2014-12-17
KR101478593B1 (ko) 2015-01-02
ES2375503T3 (es) 2012-03-01
US20210113571A1 (en) 2021-04-22
WO2008113089A1 (en) 2008-09-25
TWI406657B (zh) 2013-09-01
ATE523486T1 (de) 2011-09-15
JP2010522143A (ja) 2010-07-01
CY2020032I2 (el) 2020-11-25
CN101668738A (zh) 2010-03-10
CN104211624B (zh) 2017-12-15
US20200281933A1 (en) 2020-09-10
US20140256731A1 (en) 2014-09-11
PT2137143E (pt) 2011-12-22
AU2008229609A1 (en) 2008-09-25
US20200030335A1 (en) 2020-01-30
HK1140185A1 (en) 2010-10-08
HRP20110869T1 (hr) 2011-12-31
IL200440A (en) 2013-09-30
MY148916A (en) 2013-06-14
US20220218713A1 (en) 2022-07-14
EA018707B1 (ru) 2013-10-30

Similar Documents

Publication Publication Date Title
HUS2100001I1 (hu) Pleuromutilin származékok mikróbák által mediált betegségek kezelésére
MX2012001654A (es) Metodos para usar moduladores de c-met.
HK1139381A1 (en) Bicyclic -amino acid derivative
MX2011013306A (es) Compuestos tetraciclicos.
UA96459C2 (uk) 4-заміщені похідні феноксифенілоцтової кислоти
MXPA06009475A (es) Derivados de quinazolina y usos terapeuticos de los mismos.
PL1809288T3 (pl) Zastosowanie pochodnych 1,4-bis-(3-aminoalkilo)piperazyny do leczenia chorób neurodegeneracyjnych
TW200728258A (en) Novel compounds
MY178760A (en) Monocyclic pyridine derivative
MX2010002042A (es) Derivados de 1,3-dihidroisoindol.
TW200700071A (en) Novel use
IL200410A0 (en) Novel derivatives of psammaplin a, a method for their synthesis and their use for the prevention or treatment of cancer
MX2010004487A (es) Derivados lactamicos sustituidos y sus usos para glaucoma e hipertension ocular.
EP2100895A4 (de) Tricyclische verbindung und deren medizinische verwendung
MY162934A (en) Anticancer steroidal lactones unsaturated in position 7 (8)
TW200738681A (en) Isoquinoline and benzo[h]isoquinoline derivatives, their preparation and their use in therapeutics
GB2483195A (en) Novel uses
PL1732902T3 (pl) Pochodne nukleozydów i ich terapeutyczne zastosowanie
EP2634171A4 (de) 23-yn-vitamin-d3-derivat
UA85709C2 (ru) Производные пиридоиндолона, замещенные в положении 6, их получение и применение в терапии
UA91508C2 (ru) Конденсированное гетероциклическое соединение
MX2013014950A (es) Compuestos para el tratamiento del cancer asociado con el papilomavirus humano.
DE602007008947D1 (en) 4,5,6,7-tetrahydrothienoä2,3-cüpyridine als h3-modulatoren
NZ594996A (en) Cholestanol derivative for combined use
AR074051A1 (es) Derivados sustituidos de pirrolidina, su uso en el tratamiento de cancer y composiciones farmaceuticas que los contienen.